Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: atlast who wrote (69457)	7/25/1999 2:52:00 PM
From: Tom D	Respond to of 164684

I hope you are right. Incidentally, don't forget that the recent PCS/Rite Aid deal diluted AMZNs ownership stake significantly. AMZNs ownership stake in DSCM, post-IPO, will be 27.4%. If you are interested in digging deeper, I have collected all the information I could find on eDrugstores and started a thread with it. Here is the ownership structure of DSCM, post-IPO Message 10640483 DSCM is currently being nominally priced at $10 to $11 per share with 42 million shares outstanding, post-IPO. I am guessing the price will be around $30 per share for the first week, making AMZNs $40 Million (?) investment now worth $750 million on paper less than a year later. I find it ironic that if AMZN played the Coca Cola game and sold off assets and accounted for them as ordinary income, AMZN could cover several years of losses with DSCM alone. Tom D